Latest News by Industry
REPLIGEN CORP [RGEN] has reported fiscal Q1 profit of $28.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.51.
The Biological Products, Except Diagnostic Substances firm posted revenue of $182.70 million in this period.
Also Read: